BioCentury
ARTICLE | Tools & Techniques

Virtual ICAAC

September 24, 2001 7:00 AM UTC

The Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), which had been scheduled for this week, was postponed until Dec. 16-19 in the aftermath of the World Trade Center attack. However, a look through the abstract catalog showed several areas to watch.

These include an FDA report on adverse events with two classes of antibiotics; revelations about the mechanism of action of Cubist Pharmaceuticals Inc.'s Daptomycin; anti-hepatitis B compounds from Bayer AG; and reports by Microcide Pharmaceuticals Inc. on the therapeutic leverage being seen with its efflux pump inhibitors...